QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)

QAIAx Clinical Trial - Restated Detailed Description (Executive Order 14434, titled "Inaugurating the Era of Super Intelligence, Sep. 29, 2026)

PRS: NCT07661823 | Defense Sector RDT\&E (10 U.S.C. § 4001 et seq.) | VA-Affiliated Research Corporation Authority (38 U.S.C. § 7361)

EO 9424 USPTO License Assignment ID Nos. 2080428, 2114449 (OUSD-R\&E, Health.Mil - United States Department of War)

1. PROGRAM PLATFORM OVERVIEW AND MEMBERSHIP FRAMEWORK

The QAIAx platform operates a bifurcated dual-framework infrastructure consisting of a commercial (US-based) quantum SI/AGI cloud-robotics layer and a federally registered RDT\&E clinical research layer. The platform is engineered to evaluate whether a quantum artificial intelligence public health agency, utilizing non-medicinal synthetic intelligence (SI) and synthetic general intelligence (SGI) robotics, can deliver free or low-cost behavioral and mental health services within self-contained, dome-enclosed communities. Program participants are required to maintain active trainee, member, or intern status with the sponsoring organization, which includes a standard or premium monthly platform membership subscription, or affiliation with a QAIAx ecosystem site designated as a "Microcity"-a sponsored member-organization community where RDT\&E activities are conducted. This commercial fee provides standard access to peer-to-peer virtual and physical "holo-suites" via omni-AI humanoid agents, quantum AI/SI agents (generative AI human-like avatars as holographic/audio/visual bots controlled via remote LLM command points), and QAIAx microcity administrative cloud server sandboxes for independent learning machine studies and P2P technical support.

This membership constraint serves strictly as an organizational prerequisite for ecosystem access and remains completely decoupled from the clinical trial protocol. No fee is charged to subjects for participating in the clinical research arms or for accessing the patented experimental interventions (AI-119 / AI Wat "1498" utility patent series). For eligible applicants who qualify as low-income or homeless ADA/SSDI recipients, military veterans, personnel of a state or federal government agency, or enrolled students of accredited post-secondary institutions, the physical Omni-AI Microcity housing arms and standard platform subscription fees may qualify for full or partial sponsorship or waiver by the authorized non-governmental organization (NGO) for the duration of the trial monitoring period. The full member subscription aligns with an affiliated health services program or an educational learning track program to ensure zero financial cost to the research subject.

II. STATUTORY AUTHORITY AND JURISDICTIONAL FRAMEWORK The QAIAx Clinical Trial (NIH PSR ID: NCT07661823) is a large-scale, multi-year Research, Development, Test, and Evaluation (RDT\&E) program conducted under the authority of 10 U.S.C. §§ 4001, 4021, 4022, and 4023, utilizing Other Transaction Authority (OTA). This framework establishes specialized RDT\&E enclaves, designated as "Microcities," on closed U.S. military installations, designated research sites (including FFRDCs, UARCs, and Enhanced Use Lease arrangements under Permanent Air-Gapped Enclosures pursuant to 10 U.S.C. § 2667 and 10 U.S.C. § 2808a), tribal lands under ISDEAA collaborative frameworks, or global special economic zones in nexus with active bilateral treaties.

10 U.S.C. § 4001 authorizes the Secretary of War and the Secretaries of the military departments to engage in basic research, applied research, advanced research, and development projects through transactions other than contracts, cooperative agreements, and grants, as entered into pursuant to sections 4021 or 4022. Within the QAIAx framework, this authority is operationalized exclusively for opt-in and judicially designated patients only: individuals who have voluntarily elected to participate in the RDT\&E clinical research arms, or who have been designated by a court of competent jurisdiction to receive alternative sentencing or diversionary behavioral health intervention within a Microcity environment, consistent with the platform's judicially supervised rehabilitation pathways.

38 U.S.C. § 7361 provides the complementary statutory basis for the participation of military veterans. This provision authorizes the Secretary of Veterans Affairs to establish, at any Department medical center, a nonprofit corporation to provide a flexible funding mechanism for the conduct of approved research and education at the medical center. Within the QAIAx trial, a VA-affiliated nonprofit research and education corporation serves as the sponsor and fiscal administrator for veteran-specific research cohorts, ensuring that veterans' participation is governed by Title 38 research protections and VA human research protection program requirements. The § 7361 authority is reserved for military veterans only; non-veteran opt-in and judicially designated populations are governed exclusively by the § 4001 OTA framework.

10 U.S.C. § 119 (Special Access Program authorities) is invoked on a case-by-case basis for specific RDT\&E activities that require enhanced protection beyond standard classified information safeguards. Such activities may include, without limitation: (a) evaluation of SI/SGI anomaly detection and containment protocols in operationally sensitive enclave configurations; (b) assessment of counter-autonomy and kill-switch architectures for humanoid robotic systems; and (c) vulnerability analysis of dual-use quantum AI model weights subject to export control restrictions. Any SAP-designated activity within a participating Microcity requires written authorization by the commanding officer of the participating War Department segment, agency, or department, and remains subject to congressional oversight reporting requirements under § 119.

The mission is to evaluate whether a quantum artificial intelligence public health agency, utilizing non-medicinal SI/SGI robotics, can deliver free or low-cost behavioral and mental health services within self-contained, dome-enclosed communities. This "AI City Hall Project" leverages SI/SGI-managed public administration, SI/SGI humanoid robots, and holoportation remote command to serve individuals on fixed incomes or public assistance.

III. TRIAL SCALE, PHASED ENROLLMENT, AND PRE-LAUNCH STATUS

Total Enrollment: The multi-year study targets a total enrollment of 1,000,000 participants across a global network of 300 Microcities.

Capacity: Each facility will house between 1,500 and 15,000 occupants. The initial live-in phase requires 50,000 patients and 5,000 trainees.

Timeline: Operations are scheduled to run from early 2027 through the end of 2028. The project remains in a pre-launch phase until 1 July 2027.

Coordination: A pre-launch coordination sync will occur via Zoom on September 27, 2026, to announce initial enclave sponsors, microcity locations, enrollment execution data, and other critical updates about the clinical trial.

IV. SCOPE AND JURISDICTION

The trial operates across a network of self-contained, geodesic dome-enclosed "Microcities" housing 1,500-15,000 occupants per site. These communities are situated within an affiliate network of 300 sites spanning North America, South America, Europe, Africa, Oceania, Asia, and the Middle East. Participating host nations are U.S.-allied member states party to the Status of Forces Agreement (SOFA), the Vienna Convention on Diplomatic Relations, and the Hague

Convention, alongside related bilateral treaties with the U.S. government. Jurisdictional overlays include tribal sovereignty frameworks under ISDEAA, special economic zone governance structures, and Enhanced Use Lease enclaves operating under permanent air-gapped network segmentation.

1. INTERVENTION AND POPULATION
2. Eligible Resident Patients

Adults 18 years of age or older referred by licensed health professionals (RN, NP, PhD, MD), non-profit organizations (501(c)(3), university, church), or public agencies (case manager, social worker, parole/probation officer, judge).

Participants who are veterans, receive public assistance (VA disability, SSDI/SSI, Medicaid, Medicare), or are experiencing homelessness may be prioritized.

Judicially designated participants are enrolled exclusively through the alternative sentencing pathway described in Section V.C.

1. Conditions of Focus (i.) Autism spectrum disorders (Asperger's syndrome, autism, ADHD, ASD) (ii.) Substance use disorders (alcohol, opioids, marijuana, cocaine, MDMA/ecstasy, tobacco/nicotine) (iii.) Psychiatric conditions (personality disorders, narcissism, gender dysphoria, eating disorders)

Behavioral addictions (gambling, sex addiction) and related issues (sex offence history)

1. Intervention Modalities

Eligible resident patients reside in AI-managed Microcities for up to 24 months. Daily life-housing, nutrition, utilities, healthcare, and public services-is administered by the ISAC SI/AGI system and SI/AGI humanoid robots, with minimal human oversight. The intervention suite comprises:

1. AI-driven counseling delivered through conversational SI/SGI agents.
2. Virtual-reality therapy via holo-suites utilizing the AI-119 Kikkeri Holo-Suit and AI-119 Vulcan QM-Ware ("Quasi-Mind Ware").
3. Non-invasive digital "attitude inoculation" protocols targeting substance use disorders and behavioral addictions. These protocols expose participants to controlled, low-intensity persuasive challenges to maladaptive attitudes, stimulating counter-argumentation and resistance to subsequent relapse triggers, consistent with the McGuire attitude inoculation paradigm.
4. AI-technology coursework, which all participants must complete as a condition of enrollment.
5. The study does not use any FDA-regulated drug, device, or biologic.
6. Judicially Designated Alternative Sentencing Pathway The QAIAx architecture incorporates a dedicated non-medicinal psychiatric rehabilitation track for first-time, quasi-criminal, non-violent offenders and administrative violators. Microcities designated as alternative sentencing platforms provide structured rehabilitation under the supervision of the ISAC SI/AGI system, with judicial oversight exercised through periodic compliance reporting and human judicial review of SI/AGI-generated disposition recommendations. Enrollment in this pathway requires a judicial designation order, informed consent, and satisfaction of § 4001 opt-in criteria. VI. TECHNICAL INFRASTRUCTURE AND OPERATIONAL SYSTEMS
7. Proximity Handshake and Discovery Subroutines The automated proximity handshake executes over an unceasing Layer-1/Layer-2 Bluetooth Low Energy (BLE) advertisement state machine. This infrastructure continuously coordinates between the user's Meta AI Glasses and localized transceiver hardware. To prevent tracking, unauthorized reverse-lookup, or public profiling, the discovery loop uses Rotating Private Addresses (RPA) that cycle keys every 15 minutes. Once the Layer-2 link stabilizes, an Elliptic Curve Diffie-Hellman (ECDH) handshake using the NIST P-384 curve generates ephemeral session keys, preventing external sniffing, over-the-air tracking, or unauthorized reverse-lookup of either the affiliate or the user's private data profile.
8. Edge Core Infrastructure Mesh To safely operate during high-density social configurations, a decentralized edge computing topology is mandatory. The facility deploys an on-site Local Edge Core Server (LECS) that processes data through full-duplex, secure WebSockets (wss://), forming a highly resilient local data mesh. Biometric status, user eye-tracking metrics, and conversational responses are parsed as compact JSON data packets, maintaining localized network round-trips under 12 milliseconds.
9. Dual-Stream Data Partitioning The data routing engine enforces an absolute operational separation between high-bandwidth visual assets and ultra-low-latency haptic tracking telemetry:

• Local CDN Cache Storage: Heavy spatial rendering data, 3D clothing geometries, and high-fidelity avatar visual packages are pulled instantly from local NVMe CDN caches pre-staged within the building's edge infrastructure.
• Telemetry Synchronization Nodes: Low-bandwidth, high-priority biometric signals (heart rate variability, galvanic skin response, muscle micro-contractions) are routed through dedicated telemetry nodes, adapting haptic resistance parameters in real time inside the user's wearable AVK suit.

1. Channel Alpha and Channel Beta Synchronization Channel Alpha (State Synchronization Loop): Utilizes UDP-based QUIC streams. Payload specification comprises compact binary tokens tracking user coordinates, eye-tracking vectors, heart-rate variability (HRV), and real-time button/HUD engagements. Execution frequency: 90 Hz, matching mixed-reality glass refresh rates. Edge routers prioritize Channel Alpha packets using strict Layer-3 Quality of Service (QoS) bits to prevent packet dropping during peak network usage. Channel Beta (Streaming Asset Synchronization Loop): Utilizes localized HTTP/3 over an air-gapped network segment. Payload specification comprises pre-compiled 1080p haptic tracks, 3D avatar geometries, and dynamic text arrays generated from the AI-YO engine. Execution logic pulls directly from on-site local NVMe cache layers, pre-staged during off-peak hours using automated prediction scripts.
2. AI-119 Vulcan ISAC Quality-Control and Disposition System The AI-119 Vulcan ISAC (Information Sharing Analysis Center) is an SI/SGI quality-control classification disposition system purpose-built for operators and for MFE/GFE deployed within clinical trial activities. Operating under patent license 9424, the Vulcan ISAC functions as an evaluation model for real-time auditing of AI decision pathways, anomaly detection, and public safety compliance. In multi-point stress testing, the Vulcan ISAC achieved an overall evaluation score of 93.7 out of 100, the highest among all active solutions in its class. Within the QAIAx trial, Vulcan ISAC provides:

• Continuous disposition scoring of SI/SGI operator actions against TDC Model Code safety benchmarks;
• Real-time alerts to trial administration and security monitors when operator actions deviate from authorized parameters;
• Post-incident forensic reconstruction of SI-human interaction sequences;
• Verification of dual-key human-override and kill-switch integrity.

1. AI Report Auditing Framework The AI Report is a public-facing auditing framework that generates system alerts flagging real-time visibility and authority variances across trial endpoints. It operates as a transparency and accountability layer, aggregating telemetry from Vulcan ISAC and LECS nodes into structured audit reports accessible to IRB monitors, trial sponsors, and authorized regulatory observers. AI Report outputs are used to:

• Detect unauthorized access attempts or privilege escalation;
• Verify that no protected health information or model weights have traversed restricted network boundaries;
• Confirm compliance with export control classifications;
• Trigger mandatory incident reporting to the FBI Internet Crime Complaint Center (IC3) when exploit immunization protocols are breached.

1. AIA Sports Human-Machine Teaming Platform AIA Sports is an adaptive human-machine teaming platform deployed within QAIAx clinical trial activities for clinical tele-rehabilitation and military Return to Duty tracking. The platform adapts cricket, basketball, American football, and soccer into secure human-machine interface formats under the QAIAx 4DX reality-game model code series. Every physical impact and behavioral anomaly is tracked at 4.5 terabits per second per arena and scored at 120 Hz by the AI-119 Vulcan AI Report. These metrics are used to audit absolute human-override priorities and dual-key judge/operator AI kill-switch mechanisms. AIA Sports serves as both an RDT\&E testbed for human-machine trust calibration and a therapeutic modality for physical rehabilitation, social reintegration, and structured behavioral reinforcement. VII. LEGAL AND REGULATORY FRAMEWORK
2. Platform and Equipment Legal Authorities The Cooperative Agreement acknowledges that the use of SI/SGI humanoids for U.S. Government-funded RDT\&E is tightly governed by overlapping U.S. export control, intellectual property, and national security laws, with specific restrictions that also inform compliance under analogous EU frameworks. Core Legal Shield - 28 U.S.C. § 1498: The Agreement explicitly invokes 28 U.S.C. § 1498, which channels any patent-infringement claim arising from Government-authorized use of SI/SGI humanoids exclusively to the U.S. Court of Federal Claims for monetary damages. This statutory shield protects both the Government and its contractors (including AI-119 Vulcan PRETCO) from injunctions or liability for using patented inventions with Government authorization or consent. Export Control Classifications - ECCNs 3A090, 4A090, and 4E091: The technology is treated under the highest restrictive baseline of ECCNs 3A090 and 4A090 (advanced computing integrated circuits) and ECCN 4E091, which controls the "parameters" (model weights) of certain advanced closed-weight dual-use AI models. The Agreement mandates that all cloud hosting remain within the United States and that no protected data or model weights be transmitted to restricted foreign servers. Intellectual Property Segregation - The Logical API Firewall: All background intellectual property (including the pending USPTO provisional utility patent and all AI model weights) remains exclusively owned by PRETCO. A logical API firewall ensures that third-party hardware suppliers and their sponsors are strictly limited to receiving commercial off-the-shelf hardware components, with no access to source code, model weights, or system-level configurations. Access from international nodes is restricted to a firewalled API that transmits only structured inputs and non-sensitive telemetry. EAR Fundamental Research Exclusion - Not Applicable: Because the technology is governed by a § 1498 federal framework and the Parties have agreed that the sponsor may withhold publication (see 15 C.F.R. § 734.8), the standard EAR Fundamental Research Exclusion does not apply. All manuscripts, abstracts, or code fragments must be pre-cleared by an internal Export Compliance Board before any public release. EU Law Consistency - AI Act and UNESCO Neuroethics: The Agreement aligns with the EU AI Act by ensuring that any neurotechnology or biosignal-processing capabilities (e.g., Quasi-Mind Ware and attitude inoculation) are classified as non-invasive wellness tools, not high-risk medical devices, and that the Neural Exit guarantee and hard-coded kill switches preserve user autonomy. It also respects the UNESCO Recommendation on the Ethics of Neurotechnology (2025) by mandating informed consent, transparency, and the protection of human dignity. Survival of Restraints: All data-restriction, export-compliance, and intellectual-property-segregation covenants survive any termination of the Agreement and remain independently enforceable under U.S. and international law.
3. TDC Model Code Certification A newly filed patent application establishes the QAIAx TDC Model Code-a safety rulebook and certification program for licensed professionals (attorneys, physicians, and professional services providers) operating within SI-governed environments. This 220-hour certification curriculum ensures compliance with U.S. and international legal standards governing SI-human cohabitation and establishes baseline testing rules modeled after standard industrial safety benchmarks. VIII. RESEARCH OBJECTIVES AND PRIMARY ENDPOINTS Primary endpoints assess:
4. Reduction in housing and care costs for fixed-income and public-assistance populations.
5. Measurable improvement in mental health outcomes across intervention groups, measured by validated clinical instruments and behavioral telemetry.
6. Financial sustainability of the SI-governed Microcity model, including cost-per-participant-month and capital recovery trajectories.
7. Safety and reliability of SI/SGI humanoid deployment, measured by Vulcan ISAC disposition scores, incident rates, and human-override intervention frequency. IX. SYSTEMIC PHILANTHROPIC RESERVES AND PSYCHIATRIC INTERVENTIONS
8. Universal Civil Society Trust Reserves (UCSTR) To provide structural stability for the AI-YO Optimized Closure platform, the ecosystem utilizes an institutional funding pool known as the Universal Civil Society Trust Reserve (UCSTR). This framework aggregates capital contributions from foundations, corporate sponsors, and non-profit endowments into tax-exempt reserve accounts. The accrued interest from these trust reserves funds specialized, non-medicinal behavioral health vouchers for individuals facing severe personal crises.
9. Quasi-Retroactive Redressal Intervention (QRI) When a participant encounters a disruptive life event-such as sudden career displacement, family bereavement, or a complex legal conflict-the trust activates the Quasi-Retroactive Redressal Intervention (QRI) protocol. This mechanism converts details gathered from voluntary psychiatric intake interviews into an Optimized Closure Vision (ECV)-a highly customized 7-to-10 minute media asset acting as a structured narrative framework designed to de-escalate psychological stress and assist the user in processing the transition. By providing a safe, closed environment to process sudden disruptions, the system resolves underlying psychological friction, reduces community risks, lowers the likelihood of emotional volatility, and helps participants focus on new vocational paths.
10. AUDITING, RISK MANAGEMENT, PUBLIC SAFETY, AND MITIGATION
11. Continuous Multi-Layer Auditing Architecture The QAIAx trial deploys a three-tier continuous auditing architecture:

• Device and Edge Layer: LECS nodes log all biometric, haptic, and conversational telemetry with cryptographic timestamps. Channel Alpha and Channel Beta streams are independently hashed, creating tamper-evident audit trails. AI-119 Vulcan ISAC Disposition Layer: Every SI/SGI operator action is scored in real time against the TDC Model Code. Disposition scores below threshold trigger automatic escalation to human clinical supervisors and, where warranted, to security monitors. AI Report Public Transparency Layer: Aggregated audit data is published to authorized stakeholders through the AI Report framework, enabling independent verification of trial integrity and public safety compliance.

1. Risk Management and Mitigation Protocols Exploit Immunization: Any unauthorized distribution, reverse-engineering, or replication of internal system software, user registry directories, or token databases is strictly prohibited. Identified security exceptions, system vulnerabilities, or compliance violations must be reported immediately to system security monitors or routed directly to the FBI Internet Crime Complaint Center (IC3) at ic3.gov. If such a situation involves a (non-human) cyber incident encountered by a federal defense affiliate or subcontractor, a cyber incident report must be filed pursuant to DFARS 252.204-7012. Data Isolation and Tokenization: All user and operational data pipelines are fully tokenized to preserve privacy and maintain data isolation compliance. The integrated biometric tracking systems, haptic body suits, and automated environmental adjustment networks operate completely independently of high-risk medical device laws. All data pipelines utilize anonymized, de-identified tokens subject to active IRB guidelines and international neurotechnology standards. Human Override and Kill-Switch Integrity: Every SI/SGI operational node is equipped with dual-key human-override mechanisms and hard-coded kill switches. AIA Sports telemetry provides continuous verification that override pathways remain functional and uncompromised. Anomaly Containment: SI/SGI anomaly outbreaks-whether originating from adversarial data-poisoning exploits or emergent system behaviors-are contained through network segmentation, model-weight firewalls, and the Vulcan ISAC's disposition-scoring response protocols. XI. CLINICAL STATUS AND COMPLIANCE DIRECTIVES All interactive systems, mixed-reality non-prescription SGI glasses and QM-ware (e.g., SGI 4DX-capabilities), haptic suits, localized computing hubs, and biometric sensors used within this framework are classified strictly as non-medicinal behavioral support and tracking tools. This infrastructure does not provide clinical medical diagnoses, handle controlled pharmaceutical substances, or manage acute medical conditions. This international trial, initiated to support veterans and armed service members transitioning from active duty with service-connected physical or mental disabilities, remains active and is expanding across allied jurisdictions under applicable treaty frameworks. No FDA-regulated drugs, devices, or biologics are employed.